Unlike thrombin, protein C and activated protein C do not affect vascular tone

Peptides

Volumn 21, Issue 8, 2000, Pages 1231-1236

  Bhattacharya, Anindya ^a   Grinnell, Brian W ^a   Cohen, Marlene L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Activated protein C (APC); Protein C (PC); Thrombin; Vascular effect

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN C; THROMBIN; THROMBOMODULIN;

ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD VESSEL TONE; DRUG EFFECT; ENDOTHELIUM CELL; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RABBIT; RECEPTOR AFFINITY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMAL; AORTA; BLOOD VESSELS; CARBACHOL; CARDIOTONIC AGENTS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; POTASSIUM CHLORIDE; PROTEIN C; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THROMBIN;

EID: 0033789629     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00264-3     Document Type: Article

References (45)

1. Antonaccio M.J., Normandin D., Serafino R., Moreland S. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle. J Pharmacol Exp Ther. 266:1993;125-132.
2. Boffa M.C., Karmochkine M. Thrombomodulin an overview and potential implications in vascular disorders . Lupus. 7:1998;S120-S125.
3. Bombeli T., Mueller M., Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemost. 77:1997;408-423.
4. de Blois D., Drapeau G., Petitclerc E., Marceau F. Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of α-thrombin in rabbit aortic rings. Br J Pharmacol. 105:1992;959-967.
5. Dery O., Bunnett N.W. Proteinase-activated receptors a growing family of heptahelical receptors for thrombin, trypsin and tryptase . Biochem Soc Trans. 27:1999;246-254.
6. Ehrlich H.J., Esmon N.L., Bang N.U. In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits. J Lab Clin Med. 115:1990;182-189.
7. Esmon C.T., Gu J.M., Xu J., Qu D., Stearns-Kurosawa D.J., Kurosawa S. Regulation and functions of the protein C anticoagulant pathway. Haematologica. 84:1999;363-368.
8. Foley P.W., Irvine C.D., Standen G.R., Morse C., Smith F.T., McGrath C., Baird R.N., Lamont P.M. Activated protein C resistance, factor V Leiden and peripheral vascular disease. Cardiovas Surg. 5:1997;157-160.
9. Fujiwara Y., Tagami S., Kawakami Y. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy. J Atherosc Thromb. 5:1998;21-28.
10. Fukudome K., Esmon C.T. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 269:1994;26486-26491.
11. Fukudome K., Kurosawa S., Stearns-Kurosawa D.J., He X., Rezaie A.R., Esmon C.T. The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem. 271:1996;17491-17498.
12. Fukudome K., Ye X., Tsuneyoshi N., Tokunaga O., Sugawara K., Mizokami H., Kimoto M. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med. 187:1998;1029-1035.
13. Godin D., Marceau F., Beaule C., Rioux F., Drapeau G. Aminopeptidase modulation of the pharmacological responses to synthetic thrombin receptor agonists. Eur J Pharmacol. 253:1994;225-230.
14. Godin D., Rioux F., Marceau F., Drapeau G. Mode of action of thrombin in the rabbit aorta. Br J Pharmacol. 115:1995;903-908.
15. Gomi K., Zushi M., Honda G., Kawahara S., Matsuzaki O., Kanabayashi T., Yamamoto S., Maruyama I., Suzuki K. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood. 75:1990;1396-1399.
16. Grinnell B.W., Yan S.B. Novel antithrombotics based on modulation of the protein C pathway. Coronary Artery Dis. 9:1998;89-97.
17. Grinnell B.W., Berg D.T. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells. Am J Physiol. 270:1996;H603-H609.
18. Gruber A., Griffin J.H. Direct detection of activated protein C in blood from human subjects. Blood. 77:1992;2340-2348.
19. Gruber A., Pal A., Kiss R.G., Sas G., Griffin J.H. Generation of activated protein C during thrombolysis. Lancet. 342:1993;1275-1276.
20. Hahn R.A., MacDonald B.R., Chastain M., Grinnell B.W., Simpson P.J. Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury. J Pharmacol Exp Ther. 276:1996;1104-1110.
21. Hansen S.R., Griffin J.H., Harker L.A., Kelley A.B., Esmon C.T., Gruber A. Antithrombotic effects of thromin-induced activation of endogenous protein C. J Clin Invest. 92:1993;2003-2012.
22. Hollenberg M.D., Saifeddine M., AlAni B., Gui Y. Proteinase-activated receptor 4 (PAR(4)) action of PAR(4)-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR(1) and PAR(2) . Can J Physiol Pharmacol. 77:1999;458-464.
23. Hooper WC, Phillips DJ, Evant BL, Renshaw M. Activated protein C induction of MCP-1 in human umbilical vein endothelial cells: a possible role for endothelial cell nitric oxide synthase. Blood 90 (Supplement 1) p. 301a, 1997.
24. Inthron D., Hoffmann J.N., Hartl W.H., Muhlbayer D., Jochum M. Antithrombin III supplementation in severe sepsis beneficial effects on organ dysfunction . Shock. 8:1997;328-334.
25. Kahn M.L., Zheng Y.W., Huang W., Bigornia V., Zeng D., Moff S., Farese R.V. Jr, Tam C., Coughlin S.R. A dual thrombin receptor system for platelet activation. Nature. 394:1998;690-694.
26. Kanamaru K., Waga S., Tanaka K. Plasma levels of protein C, protein S, and antithrombin III in patients with subarachnoid haemorrhage. Acta Neurochir. 139:1997;134-140.
27. Kiechl S., Muigg A., Santer P., Mitterer M., Egger G., Oberhollenzer M., Oberhollenzer F., Mayr A., Gasperi A., Poewe W., Willeit J. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation. 99:1999;614-619.
28. Komuro T., Miwa S., Minowa T., Okamoto Y., Enoki T., Ninomiya H., Zhang X.F., Uemura Y., Kikuchi H., Masaki T. The involvement of a novel mechanism distinct from the thrombin receptor in the vasocontraction induced by trypsin. Br J Pharmacol. 120:1997;851-856.
29. Laszik Z., Mitro A., Taylor F.B. Jr, Ferrell G., Esmon C.T. Human protein C receptor is present primarily on endothelium of large blood vessels implications for the control of the protein C pathway . Circulation. 96:1997;3633-3640.
30. Luscher T.F., Barton M. Biology of the endothelium. Clin Cardiol. 20:1997;3-10.
31. Maruyama I. Biology of endothelium. Lupus. 7:(suppl. 2):1998;S41-S43.
32. Mihara H., Murai A., Handa K., Saku K., Shirai K., Tanaka K., Arakawa K. Thrombomodulin levels in patients with coronary artery disease. Artery. 22:1997;293-308.
33. Muramatsu I., Laniyonu A., Moore G.J., Hollenberg M.D. Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol. 70:1992;996-1003.
34. Nakashima M., Kanamaru M., Umemura K., Tsuruta K. Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123, in healthy male volunteers. J Clin Pharmacol. 38:1998;40-44.
35. Rapoport R.M., Draznin M.B., Murad F. Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta. Circ Res. 55:1984;468-479.
36. Sadler J.E. Thrombomodulin structure and function. Thromb Haemost. 78:1997;392-395.
37. Sakiyama N., Wakabayashi I., Hatake K., Kakishita E. Inhibitory effect of the endothelium on thrombin-induced contraction in rabbit aorta. Gen Pharmacol. 22:1991;1005-1009.
38. Sampram E.S., Lindblad B., Dahlback B. Activated protein C resistance in patients with peripheral vascular disease. J Vasc Surg. 28:1998;624-629.
39. White R.P. Pharmacodynamic effects of tosyl-arginine methyp ester (TAME) on isolated human arteries. Gen Pharmacol. 19:1988;387-392.
40. White R.P., Robertson J.T. Pharmacodynamic evaluation of human cerebral arteries in the genesis of vasospasm. Neurosurgery. 21:1987;523-531.
41. White R.P., Robertson J.T. Role of plasmin, thrombin and antithrombin III as etiological factors in delayed vasospasm. Neurosurgery. 16:1985;27-35.
42. Xu J, Esmon CT. Endothelial cell protein C receptor (EPCR) constitutively translocates into the nucleus and also mediates activated protein C, but not protein C nuclear translocation. In: XVII Congress of the International Society on Thrombosis and Haemostasis. Washington, DC, 1999. Ed:PM Mannucci; 206.
43. Yamauchi T., Umeda F., Inoguchi T., Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun. 163:1989;1404-1411.
44. Yan S.B., Razzano P., Chao Y.B., Walls J.D., Berg D.T., McClure D.B., Grinnell B.W. Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Bio/Technology. 8:1990;655-661.
45. Yang S.G., Laniyonu A., Saifeddine M., Moore G.J., Hollenberg M.D. Actions of thrombin and thrombin receptor peptide analogues in gastric and aortic smooth muscle development of bioassays for structure-activity studies . Life Sci. 51:1992;1325-1332.